TAYLORE PASSERO: Open Payments
NPI 1063938280 · EAST AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 67 payments from 14 companies in 2025. Trend: 2023 $5,497 · 2024 $14,475 · 2025 $2,173
Food & beverage: $1,110Speaker / faculty: $1,063
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 6 | $1,128 |
| CooperSurgical, Inc. | 29 | $386 |
| Exeltis, USA Inc. | 8 | $157 |
| Biogen, Inc. | 4 | $89 |
| MILLICENT US INC | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Astellas Pharma US Inc | 2 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $55 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
| Seqirus USA Inc | 1 | $24 |
Products named: NEXPLANON, Paragard T 380A, SLYND, ZURZUVAE, MYFEMBREE, Veozah, INTRAROSA, FEMLYV.
Industry payments across NY — which companies pay providers there.
